by adminTorusBrand | Dec 13, 2016 | Axim Biotechnologies, Company News, Dixie Botanicals, Kannaway
[vc_row][vc_column][vc_column_text] Forbes profiles the success of Medical Marijuana, Inc. and our family of investment companies in recent article about CBD industry. On Monday, Forbes ran an article exploring the rapid expansion of the worldwide cannabidiol (CBD)...
by adminTorusBrand | Dec 9, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences
[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. and our portfolio of investment companies are using cannabinoids to research potential new treatments for a range of medical conditions, including those that have proven notoriously hard to treat....
by adminTorusBrand | Dec 8, 2016 | HempMeds, Press Releases
HempMeds® to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry SAN DIEGO, CA–(Marketwired – December 08, 2016) – Medical Marijuana, Inc. (OTC...
by adminTorusBrand | Dec 7, 2016 | Axim Biotechnologies, Company News
AXIM® Biotechnologies, a Medical Marijuana, Inc. investment company, is back in the news again this week, revealing that the company has gained the approval necessary to start next phase clinical trials for its CanChew® Plus cannabinoid-infused chewing gum. Following...
by adminTorusBrand | Dec 7, 2016 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA –(Marketwired – December 06, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the world’s leading cannabis portfolio company and first-ever publicly traded cannabis company in the United States, announced today that its major...